Showing results (351-360 of 444) with videos related to
Sort By:
Pageof 45
The New England Journal of Medicine|October 14, 2011
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosisLuca Richeldi, Ulrich Costabel, Moises Selman, et al.Respiratory Medicine|July 5, 2015
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosisDeborah Assayag, Eric Vittinghoff, Christopher J Ryerson, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2014
Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblastsSanjay Chandriani, Daryle J DePianto, Elsa N N'Diaye, et al.The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.American Journal of Respiratory and Critical Care Medicine|July 11, 2009
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup studyClaudia Jafari, Steven Thijsen, Giovanni Sotgiu, et al.Pharmacology & Therapeutics|December 28, 2020
Idiopathic pulmonary fibrosis: Disease mechanisms and drug developmentPaolo Spagnolo, Jonathan A Kropski, Mark G Jones, et al.The Lancet. Respiratory Medicine|February 8, 2018
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?Paul J Wolters, Timothy S Blackwell, Oliver Eickelberg, et al.The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.The European Respiratory Journal|July 30, 2026
Effect of nerandomilast on survival in patients with pulmonary fibrosisJustin M Oldham, Shervin Assassi, Arata Azuma, et al.Chest|November 5, 2017
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIvan O Rosas, Hilary J Goldberg, Harold R Collard, et al.Pageof 45